Catalyst Wire Dossier Catalyst Wire Dossier

KATERZIA

AMLODIPINE · Azurity Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KATERZIA, covering 2019-07-08 to 2021-09-13. Get the full timeline:

Most recent: FDA Approved: KATERZIA — Supplemental Application (Azurity Pharmaceuticals, Inc.)

See pricing